Zura Bio (ZURA)

• Market cap: $149M
• 1 day: -2.56%
• 5 days: 1.33%
• 1 month: -21.38%
• 3 months: -48.65%
• 6 months: -34.10%
• Year to date: -47.59%
• 1 year: -52.80%
• 5 years: -68.51%
• 10 years: -68.51%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.

Employees: 15

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

263% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 8

37% more funds holding

Funds holding: 57 [Q2] → 78 (+21) [Q3]

31% more capital invested

Capital invested by funds: $115M [Q2] → $151M (+$36.1M) [Q3]

6.63% more ownership

Funds ownership: 51.75% [Q2] → 58.38% (+6.63%) [Q3]

9% more call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.14M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5 119% upside
• Avg. target: $10.67 368% upside
• High target: $15 558% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

HC Wainwright & Co. Mitchell Kapoor 25% 1-year accuracy 41 / 165 met price target	119% upside $5	Neutral Reiterated	18 Nov 2024
Chardan Capital Matthew Barcus 0% 1-year accuracy 0 / 1 met price target	426% upside $12	Buy Maintained	8 Nov 2024
Leerink Partners Faisal Khurshid 33% 1-year accuracy 3 / 9 met price target	558% upside $15	Outperform Initiated	4 Nov 2024